📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo. (2022)

First Author: Adam C

Attributed to: Palladium-activated prodrug therapy: a novel focal therapy for localised cancers of unmet need funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.1c01733

PubMed Identifier: 34979089

Publication URI: http://europepmc.org/abstract/MED/34979089

Type: Journal Article/Review

Volume: 65

Parent Publication: Journal of medicinal chemistry

Issue: 1

ISSN: 0022-2623